India Business News: Biocon has decided to set up a Rs 1,000-crore manufacturing facility at Jawahar Pharma City, a special economic zone (SEZ) near Visakhapatnam.

Biocon intends to build a new facility in Vizag, India, for manufacturing insulin products. It is a turnabout for the Indian company, which went to Malaysia with its first insulin facility, in ...

Biopharmaceuticals company, Biocon, is planning to set up a manufacturing facility in Visakahapatnam in the next six months, according to its chairperson and MD Kiran Mazumdar Shaw.

HSBC has cut the target price on Biocon Ltd. from Rs 400 to Rs 390, as it sees negative impact on earnings per share due to the company's Rs 4,500-crore qualified institutional placement that ...

Biocon and Eris have expanded a previous agreement, with Biocon selling Indian branded formulations businesses to Mumbai-based Eris for $150M.

In a filing to the stock exchange, Biocon stated, "The U.S. Food and Drug Administration (USFDA) concluded a GMP inspection of our API facility (Site 6), located at Visakhapatnam, Andhra Pradesh ...

As we previously reported, in December 2022, Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) had completed acquisition of the global biosimilars business of its long-term partner Viatris, Inc ...

Indian drugmaker Biocon , looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's wildly popular Wegovy and is ...

Viatris Inc.'s divestiture of its biosimilars business to Biocon was completed Tuesday with a $2 billion cash payment to the Canonsburg pharmaceutical company.

Biocon to set up a unit near Vizag By Our Bureau Updated - March 12, 2018 at 09:30 PM.